Top Markets
Coin of the day
Nutra Pharma Corp. Nutra Pharma Corp.

Nutra Pharma Corp.

NPHC
Classifica tra le azioni #38961
Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in... Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in obtaining, licensing, and bringing to market a variety of pharmaceutical products, cutting-edge technologies, and both homeopathic and ethical medications. The company primarily targets the U.S. market, focusing its efforts on managing conditions such as pain, neurological ailments, cancer, autoimmune diseases, and infectious diseases. Its current commercial offerings include: Nyloxin and Nyloxin Extra Strength: These products are distributed as an oral spray for alleviating lower back pain, migraines, neck and shoulder discomfort, cramps, and neuropathic pain, and as a topical gel to relieve joint pain, arthritis, and repetitive stress injuries. Pet Pain-Away: An over-the-counter (OTC) homeopathic, non-narcotic, and non-addictive solution for chronic pain in household pets. Luxury Feet: An OTC pain reliever and anti-inflammatory designed to ease foot pain or discomfort specifically caused by high heels and stilettos. Nyloxin Military Strength: A specialized formulation for pain relief aimed at the United States Military and Veteran's Administration. Equine Pain-Away: An OTC topical pain management product for horses. Beyond its existing portfolio, Nutra Pharma Corp. is also advancing several pipeline candidates: RPI-78M: In development to treat neurological conditions such as multiple sclerosis, adrenomyeloneuropathy, and amyotrophic lateral sclerosis, alongside autoimmune diseases like rheumatoid arthritis and myasthenia gravis. RPI-MN: Under investigation for viral diseases, including human immunodeficiency virus (HIV/AIDS) and herpes, as well as for general antiviral applications. RPI-78: Being developed for applications in pain and arthritis. RPI-70: Also in development for pain relief. Founded in 2000, the company is headquartered in Plantation, Florida.
Prezzo delle azioni
$0.0001
Capitalizzazione di mercato
$715.97K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-50.00%
Paese
US
Scambia Nutra Pharma Corp. (NPHC)

Categoria

Storico del prezzo dell'azione per Nutra Pharma Corp. (NPHC)
Prezzo di chiusura più alto: $0.00 il 2026-08-01

Prezzo di chiusura più basso: $100.68 il 2001-12-01
Storico del prezzo dell'azione di Nutra Pharma Corp. dal 2001 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 0.00%
2025 648.94%
2024 11.90%
2023 -62.35%
2022 -87.53%
2021 58.96%
2020 169.20%
2019 15.03%
2018 -37.56%
2017 -94.29%
2016 -86.13%
2015 -68.46%
2014 -38.63%
2013 -35.75%
2012 -87.51%
2011 19.51%
2010 -73.66%
2009 1,628.44%
2008 -32.58%
2007 -71.51%
2006 -34.09%
2005 -37.06%
2004 -55.68%
2003 58.98%
2002 -84.39%
2001 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$161.14 24.66%
DE
$36.61 23.93%
JP
$224.67 38.51%
CH
$21.30 13.79%
IN